Top Research Archives - Page 2 of 4 - PsychPartners

Atomoxetine Combo for Sleep Apnea

Medications Research Sleep Top Research

Atomoxetine Combo for Sleep Apnea

May 21, 2026by Chris Aiken, MD0

A Drug That Sustains Ketamine’s Benefits

Depression Difficult to Treat Depression Ketamine Research Top Research

A Drug That Sustains Ketamine’s Benefits

May 20, 2026by Chris Aiken, MD0

How High Is Too High? Dosing ADHD Medications

ADHD Child Psychiatry Medications Research Stimulants Top Research

How High Is Too High? Dosing ADHD Medications

May 15, 2026by Chris Aiken, MD0

Dextromethorphan for SSRI-Resistant OCD

Antidepressants Medications OCD Research Top Research

Dextromethorphan for SSRI-Resistant OCD

May 11, 2026by Chris Aiken, MD0

CBT Helps Sustain Esketamine

Depression Difficult to Treat Depression Ketamine Research Therapy Top Research

CBT Helps Sustain Esketamine

May 7, 2026by Chris Aiken, MD0

A GLP-1 Trial Changes the Score in Alcohol

Alcohol GLP1 Agonists Medications Research Research for the Public Substance Use Top Research

A GLP-1 Trial Changes the Score in Alcohol

May 5, 2026by Chris Aiken, MD0

Psilocybin in Treatment Resistant Depression

Depression Difficult to Treat Depression Medications Psychedelics Research Top Research

Psilocybin in Treatment Resistant Depression

May 1, 2026by Chris Aiken, MD0

Auvelity Approved for Agitation in Dementia

Dementia Research Top Research

Auvelity Approved for Agitation in Dementia

May 1, 2026by Chris Aiken, MD0

An Off-Label Take on Dextromethorphan for Agitation in Dementia

Dementia Research Top Research

An Off-Label Take on Dextromethorphan for Agitation in Dementia

May 1, 2026by Chris Aiken, MD0

Melatonin-Ashwagandha Combination for Sleep

Hypnotics Research Research for the Public Sleep Supplements Top Research

Melatonin-Ashwagandha Combination for Sleep

April 29, 2026by Chris Aiken, MD0

Naltrexone-Baclofen Combo for Alcohol Craving

Addiction Meds Alcohol Medications Research Substance Use Top Research

Naltrexone-Baclofen Combo for Alcohol Craving

April 28, 2026by Chris Aiken, MD1

Ketamine and Liver Risk: How Worried Should You Be?

Depression Difficult to Treat Depression Ketamine Medications Side Effects Top Research

Ketamine and Liver Risk: How Worried Should You Be?

April 22, 2026by Chris Aiken, MD0

tDCS for Treatment-Resistant Depression

Depression Difficult to Treat Depression Research Research for the Public Top Research

tDCS for Treatment-Resistant Depression

April 6, 2026by Chris Aiken, MD0

Mirtazapine Reduces Meth Use

Addiction Meds Methamphetamine Research Top Research

Mirtazapine Reduces Meth Use

April 2, 2026by Chris Aiken, MD2

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

Antipsychotics Bipolar Meds Research Schizophrenia and Psychosis Top Research

Milsaperidone (Bysanti) Approved in Bipolar and Schizophrenia

March 30, 2026by Chris Aiken, MD3

Quetiapine vs Lithium for Treatment-Resistant Depression

Antipsychotics Depression Difficult to Treat Depression Lithium Research Top Research

Quetiapine vs Lithium for Treatment-Resistant Depression

March 23, 2026by Chris Aiken, MD0

Dextromethorphan Helps When Clozapine Fails in Schizophrenia

Antipsychotics Clozapine Research Schizophrenia and Psychosis Top Research

Dextromethorphan Helps When Clozapine Fails in Schizophrenia

March 18, 2026by Chris Aiken, MD5

Flow: At-home tDCS Approved for Depression

Depression Neuromodulation/TMS Research Research for the Public Top Research

Flow: At-home tDCS Approved for Depression

March 17, 2026by Chris Aiken, MD0

A Wearable Headset for Difficult-to-Treat Depression

Depression Devices Difficult to Treat Depression Neuromodulation/TMS Research Research for the Public Top Research

A Wearable Headset for Difficult-to-Treat Depression

March 15, 2026by Chris Aiken, MD0

When to Stop: An Expert Consensus on Deprescribing Psychotropics

Deprescribing Geriatric Psychiatry Medications Research Top Research

When to Stop: An Expert Consensus on Deprescribing Psychotropics

March 11, 2026by Chris Aiken, MD0